I am expecting that in retrospect, both Novo and Eli Lilly probably wish they hadnt reported the shortage, Marta Wosinska, a health economist at the Brookings Institution, said last week on NPRs Planet Money podcast
This will streamline the filing process for future cases by allowing plaintiffs to adopt the Master Complaints allegations while adding specific details about their claims
Wegovy (semaglutide 2.4mg weekly injection) carries the chronic weight management indication
"From my perspective, both companies are treating this very intentionally and seriously as an opportunity for access," Millar said
Do not change, adjust, or discontinue medications without physician guidance
If youre not achieving your treatment targets, struggling with weight changes, fatigue, or unexplained symptomsits time to take a deeper look